Literature DB >> 32884118

NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study.

Sumin Zhao1,2, Wanyang Wang1,2, Yaoshen Wang1,2, Rui Han1,2, Chunna Fan1,2, Peixiang Ni1,2, Fengyu Guo1,2, Fanwei Zeng3, Qiaona Yang3, Yun Yang3, Yan Sun3,4, Xinhua Zhang5, Yan Chen6, Baosheng Zhu7, Wangwei Cai8, Shaoke Chen9, Ren Cai10, Xiaoling Guo11, Chonglin Zhang12, Yuqiu Zhou13, Shuodan Huang14, Yanhui Liu15, Biyan Chen16, Shanhuo Yan17, Yajun Chen18, Hongmei Ding19, Xuan Shang20, Xiangmin Xu20, Jun Sun21,22, Zhiyu Peng23.   

Abstract

In this study, we performed a spinal muscular atrophy carrier screening investigation with NGS-based method. First, the validation for NGS-based method was implemented in 2255 samples using real-time PCR. The concordance between the NGS-based method and real-time PCR for the detection of SMA carrier and patient were up to 100%. Then, we applied this NGS-based method in 10,585 self-reported normal couples (34 Chinese ethnic groups from 5 provinces in South China) for SMA carrier screening. The overall carrier frequency was 1 in 73.8 (1.4%). It varied substantially between ethnic groups, highest in Dai ethnicity (4.3%), and no significant difference was found between five provinces. One couple was detected as carriers with an elevated risk of having an SMA affected baby. The distribution of SMN1:SMN2 genotype was also revealed in this study. Among the individuals with normal phenotype, the exon 7 copy-number ratio of SMN1 to SMN2 proved the gene conversion between them. With NGS-based method, we investigated SMA carrier status in Chinese population for the first time, and our results demonstrated that it is a promising alternative for SMA carrier screening and could provide data support and reference for future clinical application.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32884118      PMCID: PMC7852551          DOI: 10.1038/s41431-020-00714-8

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  3 in total

1.  [Screening for spinal muscular atrophy mutation carriers among 4931 pregnant women from Liuzhou region of Guangxi].

Authors:  Jianqiang Tan; Xu Zhang; Yuanliu Wang; Shiqiang Luo; Fanghua Yang; Bailing Liu; Ren Cai
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2018-08-10

2.  A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

Authors:  U R Monani; C L Lorson; D W Parsons; T W Prior; E J Androphy; A H Burghes; J D McPherson
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

3.  [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].

Authors:  Bo Gong; Li Zhang; Ya-ping Hou; He-yu Hu; Hai-chuan Li; Mei-yu Tan; Jin Chen; Jing Yu
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2013-12
  3 in total
  2 in total

1.  Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene.

Authors:  Sumin Zhao; Yaoshen Wang; Xiuqing Xin; Zhonghai Fang; Linlin Fan; Zhiyu Peng; Rui Han; Chaonan Shi; Yixiang Zhang; Chuang Fan; Jun Sun; Xuelian He
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 2.  History of development of the life-saving drug "Nusinersen" in spinal muscular atrophy.

Authors:  Jiaying Qiu; Liucheng Wu; Ruobing Qu; Tao Jiang; Jialin Bai; Lei Sheng; Pengchao Feng; Junjie Sun
Journal:  Front Cell Neurosci       Date:  2022-08-12       Impact factor: 6.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.